Janus Henderson Global Life Sciences Fund Class S (JFNSX) – aksjefondkurser og nyheter

StartsideJFNSX • Aksjefond

Janus Henderson Global Life Sciences Fund Class S

78,43 $

23. jan. · USD · MUTF · Ansvarsfraskrivelse

Janus Henderson Global Life Sciences Fund Class C

68,88 $

JFNCX0,61 %

Janus Henderson Global Life Sciences Fund Class A

80,84 $

JFNAX0,59 %

Janus Henderson Global Life Sciences Fund Class I

83,19 $

JFNIX0,59 %

Janus Henderson Global Life Sciences Fund Class T

82,44 $

JAGLX0,59 %

Janus Henderson Global Life Sciences Fund Class D

83,01 $

JNGLX0,59 %

Janus Henderson Global Life Sciences Fund Class N

82,86 $

JFNNX0,59 %

Fidelity Advisor Biotechnology Fund - Class I

42,28 $

FBTIX1,58 %

Fidelity Advisor Biotechnology Fund - Class A

38,36 $

FBTAX1,59 %

BlackRock Health Sciences Opportunities Portfolio Investor C Shares

50,82 $

SHSCX0,80 %

BlackRock Health Sciences Opportunities Portfolio Service Shares

66,18 $

SHISX0,81 %

Aksjefond

Forrige sluttkurs

78,89 $

Utbytte hittil i år

24,35 %

Omkostningsprosent

1,18 %

Kategori

Healthcare Sector Equity

Morningstar Rating

Nettoaktiva

28,76 mill. USD

Avkastning

0,22 %

Kjøpsgebyr

Opprettelsesdato

6. juli 2009

Markedsnyheter

The Globe and Mail

for 35 minutter siden

Every Stock in This Index Group Is Up Double-Digits in 2026

.INX

0,033 %

Simply Wall Street

for 42 minutter siden

BayCom Corp (NASDAQ:BCML) Annual Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Top catalysts for S&P 500 Index, VOO, and SPY ETFs this week

Investor's Business Daily

for 34 minutter siden

Dow Jones Futures: Trump Threatens 100% Canada Tariff, Government Shutdown Risks Spike; Earnings Wave Looms

.DJI

0,58 %

Yahoo Finance

for 46 minutter siden

The past year for Shoe Carnival (NASDAQ:SCVL) investors has not been profitable

The case for active management when so few outperform the S&P 500

.INX

0,033 %